Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CBER
Pharma
Ex-CBER chief says FDA layoffs threaten future drug reviews: BMO
A former official warned that mass layoffs at the FDA could disrupt its review process, according to analysts with BMO Capital Markets.
Fraiser Kansteiner
Apr 17, 2025 2:55pm
Former CBER head Peter Marks details forced exit from FDA: AP
Apr 8, 2025 5:20pm
FDA turmoil compounds challenges for cell and gene therapy field
Apr 2, 2025 3:16pm
FDA taps insider Scott Steele to lead CBER on acting basis
Apr 2, 2025 11:30am
CBER chief Peter Marks resigns from FDA
Mar 31, 2025 10:50am
FDA's Peter Marks shares more on CAR-T secondary cancer probe
Jan 25, 2024 10:42am
